FOI public interest
The Trust publishes responses to Freedom of Information requests that it considers would be of wider public interest.
Back to the list
Disclosures (August 2022) Part 2
- W22FOI294 Diabetes specialist units.pdf [pdf] 99KB
- W22FOI295 Paxlovid (nirmatrelvir with ritonavir).pdf [pdf] 100KB
- W22FOI296 Tranexamic acid (TXA) administration.pdf [pdf] 106KB 22FOI296 Hospital.xlsx [xlsx] 8KB
- W22FOI297 Mobile Phone & Data Contracts.pdf [pdf] 140KB
- W22FOI298 Patients Treated (Revolade, Nplate, Doptelet, Tavlesse).pdf [pdf] 111KB
- W22FOI299 Quality assurance software systems.pdf [pdf] 104KB
- W22FOI300 Non-metal (plastic) fistual cannulas.pdf [pdf] 94KB 22FOI300 FOI attachment.xlsx [xlsx] 10KB
- W22FOI302 Myelofibrosis Treatment.pdf [pdf] 114KB
- W22FOI303 Orthopaedic Consultants.pdf [pdf] 56KB
- W22FOI304 Treatment of Melanoma.pdf [pdf] 144KB
- W22FOI305 Telephony and Storage Contracts.pdf [pdf] 56KB ,
- W22FOI308 External Insourcing Providers.pdf [pdf] 123KB
- W22FOI309 Prehabilitation Services.pdf [pdf] 52KB 22FOI309 Attachment - FOI questions.docx [docx] 32KB
- W22FOI310 Staff Employed in Marketing, PR, Communications and Engagement Roles.pdf [pdf] 101KB
- W22FOI311 Treatment for Lung Cancer.pdf [pdf] 125KB
- W22FOI312 Neonatal Sepsis Guidance, Procedures, and Infection Diagnosis.pdf [pdf] 56KB 22FOI312 attachment - (SIC4) Neonatal infection prevention and treatment.pdf [pdf] 195KB
- W22FOI313 Parking charge notices issued at the Trust's car parks by a private operator.pdf [pdf] 131KB
- W22FOI314 Trust Operating Theatres.pdf [pdf] 52KB 22FOI314 Attachment - Operating theatres FOI (05.09.22).xlsx [xlsx] 10KB
- W22FOI315 Provider of Hard Facilities Management.pdf [pdf] 138KB
- W22FOI316 Breast Cancer Treatment.pdf [pdf] 94KB
- W22FOI317 Management of Implantable Cardiac Devices.pdf [pdf] 181K
- W22FOI318 EPRR Communication and Information Management.pdf [pdf] 99KB
Page footer image
